Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gene therapy. Clinical potential and relationship to drug treatment.

× No keyword cloud information.

85 in total

Review 1. Mosaicism induced by gene insertion as a means of improving chemotherapeutic selectivity.

Authors: F L Moolten
Journal: Crit Rev Immunol Date: 1990 Impact factor: 2.214

2. Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses.

Authors: J F Engelhardt; Y Yang; L D Stratford-Perricaudet; E D Allen; K Kozarsky; M Perricaudet; J R Yankaskas; J M Wilson
Journal: Nat Genet Date: 1993-05 Impact factor: 38.330

3. Correction of glucocerebrosidase deficiency after retroviral-mediated gene transfer into hematopoietic progenitor cells from patients with Gaucher disease.

Authors: J K Fink; P H Correll; L K Perry; R O Brady; S Karlsson
Journal: Proc Natl Acad Sci U S A Date: 1990-03 Impact factor: 11.205

4. The chemotherapeutic exploitation of virus-specified enzymes.

Authors: G B Elion
Journal: Adv Enzyme Regul Date: 1980

5. Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy.

Authors: F L Moolten
Journal: Cancer Res Date: 1986-10 Impact factor: 12.701

6. A genetic therapy for familial hypercholesterolemia.

Authors: D A Dichek; G L Bratthauer; Z H Beg; K D Newman; K D Anderson; J A Zwiebel; J M Hoeg; W F Anderson
Journal: Trans Assoc Am Physicians Date: 1990

7. Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol.

Authors: L Xu; S K Stahl; H P Dave; R Schiffmann; P H Correll; S Kessler; S Karlsson
Journal: Exp Hematol Date: 1994-02 Impact factor: 3.084

8. A controlled, Phase 1 clinical trial to evaluate the safety and effects in HIV-1 infected humans of autologous lymphocytes transduced with a ribozyme that cleaves HIV-1 RNA.

Authors: F Wong-Staal; E M Poeschla; D J Looney
Journal: Hum Gene Ther Date: 1998-11-01 Impact factor: 5.695

9. The "bystander effect": tumor regression when a fraction of the tumor mass is genetically modified.

Authors: S M Freeman; C N Abboud; K A Whartenby; C H Packman; D S Koeplin; F L Moolten; G N Abraham
Journal: Cancer Res Date: 1993-11-01 Impact factor: 12.701

10. Antimetastatic vaccination of tumor-bearing mice with two types of IFN-gamma gene-inserted tumor cells.

Authors: A Porgador; R Bannerji; Y Watanabe; M Feldman; E Gilboa; L Eisenbach
Journal: J Immunol Date: 1993-02-15 Impact factor: 5.422